Lichen International Ltd (LICN) FinancialsLICNLichen International Ltd

Evaluating the bottom line, Lichen International Ltd maintains a gross margin of N/A. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at N/A, while the net margin is N/A. These profitability ratios, combined with a Return on Equity (ROE) of -38.61%, provide a clear picture of how effectively LICN converts its operational activities into shareholder value.

In the context of the broader market, LICN competes directly with industry leaders such as XHLD and TDIC. With a market capitalization of $8.25M, it holds a leading position in the sector. When comparing efficiency, LICN's gross margin of 15.06% stands against XHLD's 84.27% and TDIC's 0.05%. Such benchmarking helps identify whether Lichen International Ltd is trading at a premium or discount relative to its financial performance.

Lichen China Ltd has shown a significant decline in revenue, dropping from $23.38 million in Q1 2025 to $10.26 million in Q1 2026. The gross margin has also decreased, indicating challenges in maintaining profitability. The company reported a net loss of $12.61 million in Q1 2026, which raises concerns about its financial health.